Existing Subscriber? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

FDA Budget May Need To Be Trimmed 5% In FY 2015

This article was originally published in The Pink Sheet Daily

31 May 2013
News

Derrick Gingery @dgingery derrick.gingery@informa.com

Executive Summary

OMB memo states that agencies should reduce net discretionary spending from the initial FY 2015 estimate and provide options for additional cuts.

Existing Subscriber? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
BioPharmaceutical
Regions
North America

United States

Subjects
Legislation

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical United States Legislation

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS075771

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS075771

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

FDA Budget May Need To Be Trimmed 5% In FY 2015

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

FDA Budget May Need To Be Trimmed 5% In FY 2015

News

Executive Summary

Related Content

U.S. FDA To Close Office In Amman, Jordan; Says It Is Still Committed To MENA Region

FDA To Close Office In Amman, Jordan; Operations Moving To White Oak

FDA’s Sequestered User Fees From FY 2013 Likely Gone, But FY 2014 Fees Could Be Exempted

FDA’s Autor Moves To Mylan: Company’s Gain May Also Be Company’s Loss

FDA’s Budget Proposal: It’s The User Fees’ Agency Now

FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus

FDA Dependence on User Fees Would Increase Under FY 2012 Budget Request

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert